Back to discover
Disease
Glucosephosphate Dehydrogenase Deficiency
Clinical development underwayEmerging research
1
Publications
2
Clinical trials
2024
Latest publication
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this disease.
The global role of G6PD in infection and immunity.
Research2024-06-13Frontiers in immunology
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
No activity recorded in this window. Try a wider timeframe.
Clinical trials
The current development programme across all trial phases.
Clinical programme
2
0
0
2
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Most influential
Recent publications
Major themes2
- Glucosephosphate Dehydrogenase1
- Glucosephosphate Dehydrogenase Deficiency1
Leading journals1
- Frontiers in immunology1
Leading researchers4
- Francis RO1
- Karafin MS1
- Shah SS1
- Stone EF1
Affiliations (unnormalised)2
- Columbia University1
- Department of Pathology and Laboratory Medicine1
Reference
Authoritative identity, definition & identifiers.
Defined in MeSH
A disease-producing enzyme deficiency subject to many variants, some of which cause a deficiency of GLUCOSE-6-PHOSPHATE DEHYDROGENASE activity in erythrocytes, leading to hemolytic anemia.
References & data sources
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.